Invesco India Pharma and Healthcare Fund Regular Growth is a Sector - Healthcare mutual fund scheme from Invesco Asset Management (India) Private Ltd. The fund was launched on 7 September 2026 and is managed by Aditya Khemani. As of 15 October 2026, the fund has an AUM of ₹435.52 Cr and its latest NAV is ₹9.12. The fund has a Very High Risk risk rating.
The fund allows minimum SIP of ₹100 and lumpsum investment starting from ₹1,000.
The fund primarily invests in Healthcare and its top holdings include Max Healthcare Institute Ltd Ordinary Shares, Sun Pharmaceuticals Industries Ltd, Sai Life Sciences Ltd, Apollo Hospitals Enterprise Ltd, and Manipal Health Enterprises Ltd. The fund has delivered -8.8% annualised returns since inception.
Invesco India Pharma and Healthcare Fund Regular Growth may be suitable for investors looking for Sector - Healthcare and who are comfortable with Very High Risk risk.






